M&A

Teva CFO eyes small US acquisitions
Globes, Israel
Thu, 06/12/14 - 10:03 am
Teva Pharmaceuticals
M&A
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
The Valeant Strategy: A Sustainable Model or a Shell Game?
WSJ Online
Thu, 06/12/14 - 09:28 am
Valeant Pharmaceuticals
M&A
Allergan
A New Bid For AstraZeneca plc In November?
Motley Fool
Thu, 06/12/14 - 09:20 am
M&A
AstraZeneca
Pfizer
Why Did Merck Pay Such A Huge Premium For Idenix
Seeking Alpha
Wed, 06/11/14 - 08:12 pm
Merck
Idenix
hepatitis C
M&A
Pfizer CFO Says AstraZeneca Deal Broke Down Over Price
Bloomberg
Wed, 06/11/14 - 11:58 am
Pfizer
AstraZeneca
M&A
Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer
Yahoo/AP
Tue, 06/10/14 - 07:23 pm
hostile bid
Allergan
M&A
Valeant Pharmaceuticals
Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
Seeking Alpha
Tue, 06/10/14 - 07:19 pm
Idenix
Merck
M&A
hepatitis C
Sovaldi
Gilead Sciences
Medtronic confirms Corventis buy, expects to close this month
Mass Device
Tue, 06/10/14 - 11:00 am
Medtronic
Corventis
M&A
devices
Allergan Board Rejects Valeant’s Latest $54 Billion Bid
Bloomberg
Tue, 06/10/14 - 10:43 am
Allergan
Valeant Pharmaceuticals
M&A
AstraZeneca: Pfizer Wants It, So Should You
Seeking Alpha
Tue, 06/10/14 - 10:38 am
Pfizer
AstraZeneca
Novartis
Teva Pharmaceuticals
M&A
Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery
Forbes
Tue, 06/10/14 - 09:38 am
R&D
M&A
Pfizer
Wyeth
GSK
Novartis
After Idenix: The Next Four Biotech Buyout Candidates
24/7 Wall St
Tue, 06/10/14 - 08:43 am
Idenix
M&A
Merck
Biocryst
Dynavax
InterMune
Vertex Pharmaceuticals
Gilead Down On Merck-Idenix Deal, But Little To Fear
Seeking Alpha
Mon, 06/9/14 - 02:50 pm
Gilead Sciences
Merck
Idenix
hepatitis C
M&A
HCV players moving after Merck buys Idenix
The Fly on the Wall
Mon, 06/9/14 - 12:01 pm
Merck
Gilead Sciences
Idenix
M&A
Achillion
JNJ
AbbVie
Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Merck
Gilead Sciences
Idenix
M&A
hepatitis C
Ackman says followed the rules with Allergan investment
Reuters
Mon, 06/9/14 - 09:42 am
Bill Ackman
Allergan
M&A
Valeant Pharmaceuticals
Achillion Pharma Might be Next Hep C Takeout Target
TheStreet.com
Mon, 06/9/14 - 09:40 am
Achillion
hepatitis C
M&A
JNJ
AbbVie
Merck
Idenix
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C
Forbes
Mon, 06/9/14 - 09:24 am
Merck
hepatitis C
M&A
Idenix
Ackman says Allergan holders back takeover at $180
Reuters
Mon, 06/9/14 - 09:23 am
Bill Ackman
Allergan
Valeant Pharmaceuticals
M&A

Pages